AllianceBernstein
TCRT icon

AllianceBernstein’s Alaunos Therapeutics TCRT Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-213,560
Closed -$139K 3363
2022
Q1
$139K Buy
213,560
+700
+0.3% +$456 ﹤0.01% 3059
2021
Q4
$232K Sell
212,860
-16,900
-7% -$18.4K ﹤0.01% 3012
2021
Q3
$418K Sell
229,760
-10,468
-4% -$19K ﹤0.01% 2816
2021
Q2
$634K Buy
240,228
+22,500
+10% +$59.4K ﹤0.01% 2704
2021
Q1
$784K Buy
217,728
+40,700
+23% +$147K ﹤0.01% 2486
2020
Q4
$446K Sell
177,028
-30,500
-15% -$76.8K ﹤0.01% 2635
2020
Q3
$523K Sell
207,528
-12,600
-6% -$31.8K ﹤0.01% 2498
2020
Q2
$722K Buy
220,128
+8,600
+4% +$28.2K ﹤0.01% 2371
2020
Q1
$518K Sell
211,528
-10,132
-5% -$24.8K ﹤0.01% 2330
2019
Q4
$1.05M Sell
221,660
-11,700
-5% -$55.2K ﹤0.01% 2253
2019
Q3
$999K Hold
233,360
﹤0.01% 2236
2019
Q2
$1.36M Sell
233,360
-4,032
-2% -$23.5K ﹤0.01% 2172
2019
Q1
$914K Sell
237,392
-39,579
-14% -$152K ﹤0.01% 2277
2018
Q4
$518K Sell
276,971
-859
-0.3% -$1.61K ﹤0.01% 2457
2018
Q3
$889K Buy
277,830
+43,611
+19% +$140K ﹤0.01% 2372
2018
Q2
$707K Buy
234,219
+39,700
+20% +$120K ﹤0.01% 2461
2018
Q1
$763K Hold
194,519
﹤0.01% 2366
2017
Q4
$805K Hold
194,519
﹤0.01% 2375
2017
Q3
$1.19M Hold
194,519
﹤0.01% 2169
2017
Q2
$1.21M Hold
194,519
﹤0.01% 2182
2017
Q1
$1.23M Hold
194,519
﹤0.01% 2119
2016
Q4
$1.04M Hold
194,519
﹤0.01% 2220
2016
Q3
$1.1M Hold
194,519
﹤0.01% 2170
2016
Q2
$1.07M Hold
194,519
﹤0.01% 2172
2016
Q1
$1.44M Buy
194,519
+2,500
+1% +$18.5K ﹤0.01% 1862
2015
Q4
$1.6M Sell
192,019
-2,969
-2% -$24.7K ﹤0.01% 1800
2015
Q3
$1.76M Sell
194,988
-209
-0.1% -$1.88K ﹤0.01% 1745
2015
Q2
$2.34M Buy
195,197
+73,097
+60% +$877K ﹤0.01% 1650
2015
Q1
$1.32M Buy
122,100
+25,100
+26% +$270K ﹤0.01% 2024
2014
Q4
$492K Hold
97,000
﹤0.01% 2510
2014
Q3
$256K Hold
97,000
﹤0.01% 2686
2014
Q2
$391K Buy
97,000
+8,983
+10% +$36.2K ﹤0.01% 2578
2014
Q1
$403K Sell
88,017
-14,498
-14% -$66.4K ﹤0.01% 2507
2013
Q4
$445K Hold
102,515
﹤0.01% 2475
2013
Q3
$405K Sell
102,515
-13,331
-12% -$52.7K ﹤0.01% 2560
2013
Q2
$243K Buy
+115,846
New +$243K ﹤0.01% 2778